DELX (Delex Healthcare Group) Total Receivables: $0.08 Mil (As of Sep. 2023)


What is Delex Healthcare Group Total Receivables?

Delex Healthcare Group DELX Total Receivables is $0.08 Mil as of Sep. 2023.

Delex Healthcare Group's Total Receivables for the quarter that ended in Sep. 2023 was $0.08 Mil.

Delex Healthcare Group Total Receivables Related Terms

Delex Healthcare Group Total Receivables Historical Data

* Premium members only.

The historical data trend for Delex Healthcare Group's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delex Healthcare Group Total Receivables Chart

Delex Healthcare Group Annual Data
Trend
Total Receivables

Delex Healthcare Group Semi-Annual Data
Sep22 Sep23
Total Receivables 0.00 0.08

Delex Healthcare Group Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $0.08 Mil mean?
Delex Healthcare Group (DELX) has a Total Receivables of $0.08 Mil as of Sep. 2023. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Delex Healthcare Group and its competitors.
Is Delex Healthcare Group's Total Receivables too high?
Delex Healthcare Group's current Total Receivables is $0.08 Mil.
How does Delex Healthcare Group's Total Receivables compare to PIAC and PWM?
Delex Healthcare Group's Total Receivables of $0.08 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Delex Healthcare Group and its competitors. Delex Healthcare Group's current Total Receivables is $0.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delex Healthcare Group stock overvalued right now?
Delex Healthcare Group (DELX) has a current Total Receivables of $0.08 Mil. The current Total Receivables is $0.08 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Delex Healthcare Group (DELX), the current Total Receivables is $0.08 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Delex Healthcare Group Business Description

Address Carnation Street, Blk 4, Lot 4, Cor., Magnolia, Novaliches, Quezon City, PHL, 1109
Delex Healthcare Group Inc is a healthcare-focused organization engaged in pharmaceutical and healthcare-related businesses.